ZimVie is a medical technology company. In the spine products market, Co. designs, manufactures and distributes a suite of spinal surgery solutions to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. Co.'s portfolio includes implants, instrumentation, biologics and bone healing technologies. Co. also provides motion preserving products in its spine portfolio, including Mobi-C® Cervical Disc and The Tether device. In the dental products market, Co. designs, manufactures and distributes a portfolio of dental implant solutions, biomaterials and digital dentistry solutions. The ZIMV average annual return since 2022 is shown above.
The Average Annual Return on the ZIMV average annual return since 2022 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether ZIMV average annual return since 2022 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ZIMV average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|